stearic acid Report issue

Animal product Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Zinc stearate is a mild antiseptic and astringent, and it has been used as a local soothing application for inflammatory and irritating skin diseases. Zinc stearate is primarily used in pharmacuetical formulations as a lubricant in tablet and capsule manufacture at concentrations up to 1.5% w/w. It is a protective agent used in powders and ointments in the treatment of eczema, acne, and other skin diseases. GRAS - Zinc stearate complies with FDA Standard CFR 21 sections 177.2600, 182.8994 and 178.2010.   NCATS

Chemistry

  • SMILES: [Zn++].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O
  • InChIKey: XOOUIPVCVHRTMJ-UHFFFAOYSA-L
  • Mol. Mass: 632.348
  • ALogP: 6.33
  • ChEMBL Molecule:
    stearic acid  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

1-heptadecanecarboxylic acid | aluminum monostearate | aluminum tristearate | ammonium stearate | calcium stearate | cetylacetic acid | fatty acids c16-18 | magnesium stearate | n-octadecanoic acidd | octadecanoic acid | octadecansaeure | octadecoic acid | ola | sodium stearate | stearate | stearic acid | stearin | stearinsaeure | zinc stearate

Organizations (15)

Research & Development (15)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (3)


 

Renal Insufficiency, Chronic (approved 2000)

Skin Diseases (approved 2017)

Sunburn (approved 2017)

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Dermatology (Phase 2)

Diabetes Mellitus, Type 2 (Phase 1)

Diabetic Foot (Phase 1)

Dyslipidemias (Phase 1)

Exanthema (Phase 2)

Gastroesophageal Reflux (Phase 4)

Hypercholesterolemia (Phase 1)

Periodontitis ()

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial Organizations: 15

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue